Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

siRNA targeting mCD14 inhibits TNF-α, MIP-2, and IL-6 secretion and NO production from LPS-induced RAW264.7 cells

Abstract

Innate immunity plays a key role in protecting a host against invading microorganism, including Gram-negative bacteria. Cluster of differentiation antigen 14 (CD14) is an important innate immunity molecule, existing as a soluble (sCD14) and membrane-associated (mCD14) protein. Endotoxin [lipopolysaccharide (LPS)] is recognized as a key molecule in the pathogenesis of sepsis and septic shock caused by Gram negative bacteria. Emerging evidences indicate that upstream inhibition of bacterial LPS/Toll-like receptor 4(TLR4)/CD14-mediated inflammation pathway is an effective therapeutic approach for attenuating damaging immune activation. RNA interference (RNAi) provides a promising approach to down-regulate gene expression specifically. To explore the possibility of using RNAi against mCD14 as a strategy for inhibiting the secretion of cytokines and the nitric oxide (NO) production from LPS-activated RAW264.7 cells, four different short interfering RNA (siRNA) molecules corresponding to the sequence of mCD14 gene were designed and synthesized. We then tested the inhibition effects of these siRNA molecules on mCD14 expression by real-time quantitative RT-PCR and Western blot. After effective siRNA molecule (mCD14–siRNA-224), which is capable of reducing messenger RNA (mRNA) accumulation and protein expression of mCD14 specifically, was identified, RAW264.7 cells pretreated with mCD14–siRNA-224 were stimulated with LPS, and the secretion of tumor necrosis factor alpha (TNF-α), macrophage inflammatory protein-2 (MIP-2) and interleukin-6 (IL-6) and the NO production were evaluated. The results indicated that mCD14–siRNA-224 effectively inhibited TNF-α, MIP-2, and IL-6 release and NO production from LPS-stimulated RAW 264.7 cells by down-regulating mRNA accumulation and protein expression of mCD14 specifically. These findings provide useful information for the development of RNAi-based prophylaxis and therapy for endotoxin-related diseases.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

References

  1. Avni D, Ernst O, Philosoph A, Zor T (2010) Role of CREB in modulation of TNFα and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Mol Immunol 47:1396–1403

  2. Brass DM, Hollingsworth JW, McElvania-Tekippe E, Garantziotis S, Hossain I, Schwartz DA (2007) CD14 is an essential mediator of LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol 293:L77–L83

  3. Bryan RM, Steven FD (2009) The road to therapeutic RNA interference (RNAi) tackling the 800 pound siRNA delivery gorilla. Discover Med 8:253–256

  4. Buczynski MW, Stephens DL, Bowers-Gentry RC, Grkovich A, Deems RA, Dennis EA (2007) TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 Cells. J Biol Chem 282:22834–22847

  5. Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM (1993) Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide (monocytes/endotoxin shock). Proc Natl Acad Sci USA 90:2380–2384

  6. Gomes NE, Brunialti MK, Mendes ME, Freudenberg M, Galanos C, Salomão R (2010) Lipopolysaccharide-induced expression of cell surface receptors and cell activation of neutrophils and monocytes in whole human blood. Braz J Med Biol Res 43:853–859

  7. Hannon GJ (2002) RNA interference. Nature 418:244–251

  8. Haziot A, Ferrero E, Köntgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM (1996) Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4:407–414

  9. He Y, Reichow S, Ramamoorthy S, Ding X, Lathigra R, Craig JC, Sobral BW, Schurig GG (2006) Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages. Infect Immun 74:5035–5046

  10. Hesslinger C, Strub A, Boer R, Ulrich WR, Lehner MD, Braun C (2009) Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochem Soc Trans 37:886–891

  11. Huber M, Kalis C, Keck S, Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Beutler B, Galanos C, Freudenberg MA (2006) R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur J Immunol 36:701–711

  12. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M, Beutler B (2005) CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6:565–570

  13. Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23(4):457–462

  14. Kang JS, Kim HM, Choi IY, Han SB, Yoon YD, Lee H, Park KH, Cho IJ, Lee CW, Lee K, Lee KH, Park SK (2010) DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway. J Pharmacol Exp Ther 334:657–664

  15. Kim JW, Kim C (2005) Inhibition of LPS-induced NO production by taurine chloramine in macrophages is mediated though Ras-ERK-NF-kappaB. Biochem Pharmacol 70(9):1352–1360

  16. Kojima K, Musch MW, Ropeleski MJ, Boone DL, Ma A, Chang EB (2004) Escherichia coli LPS induces heat shock protein 25 in intestinal epithelial cells through MAP kinase activation. Am J Physiol Gastrointest Liver Physiol 286:G645–G652

  17. Kong L, Ge B (2008) MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Cell Res 18:745–755

  18. Lichtman SN, Wang J and Lemasters JJ (1998) LPS receptor CD14 participates in release of TNF-α in RAW 264.7 and peritoneal cells but not in Kupffer cell. Am J Physiol 275:39–46

  19. Liu J, Batkai S, Pacher P, White JH, Wagner JA, Cravatt BF, Gao B, Kunos (2003) Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK Phosphoinositide3-Kinase/NF-κB independently of platelet-activating factor. J Biol Chem 278: 45034–45039

  20. Lu XZ, Yang GD, Zhang J, Fu HY, Jin L, Wei MY, Wang L, Lu ZF (2011) The sense strand pre-cleaved RNA duplex mediates an efficient RNA interference with less off-target and immune response effects. Appl Microbiol Biotechnol 90:583–586

  21. McCoy SL, Kurtz SE, Hausman FA, Trune DR, Bennett RM, Hefeneider SH (2004) Activation of RAW264.7 macrophages by bacterial DNA and lipopolysaccharide increases cell surface DNA binding and internalization. J Biol Chem 279:17217–17223

  22. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D (2001) Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNFα by blocking the binding of LPS to CD14+ cells. J Immunol 167:3329–3338

  23. Park PH, McMullen MR, Huang H, Thakur V, Nagy LE (2007) Short-term treatment of RAW264.7 macrophages with adiponectin increases TNFα expression via ERK1/2 activation and Egr-1 expression: role of TNFα in adiponectin-stimulated interleukin-10 production. J Biol Chem 282:21695–21703

  24. Triantafilou M, Triantafilou K, Fernandez N (2000) Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influenced by endotoxin concentration. Eur J Biochem 267:2218–2226

  25. Verbon A, Dekkers PE, ten Hove T, Hack CE, Pribble JP, Turner T, Souza S, Axtelle T, Hoek FJ, van Deventer SJ, van der Poll T (2001) IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol 166:3599–3605

  26. Yamazaki Y and Kawano Y (2011) Inhibitory effects of herbal alkaloids on the tumor necrosis factor-α and nitric oxide production in lipopolysaccharide-stimulated RAW264 macrophages. Chem Pharm Bull (Tokyo) 59(3):388–391

  27. Zhao L, Tao JY, Zhang SL, Pang R, Jin F, Dong JH, Guo YJ (2007) Inner anti-inflammatory mechanisms of petroleum ether extract from Melilotus suaveolens. Inflammation 30(6):213–223

Download references

Acknowledgment

This study was financially supported by the Major National Science and Technology Specific Projects (2009ZX08007-009B)

Author information

Correspondence to Fengyang Wang.

Additional information

M. Lei, H. Jiao and T. Liu contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lei, M., Jiao, H., Liu, T. et al. siRNA targeting mCD14 inhibits TNF-α, MIP-2, and IL-6 secretion and NO production from LPS-induced RAW264.7 cells. Appl Microbiol Biotechnol 92, 115–124 (2011). https://doi.org/10.1007/s00253-011-3371-7

Download citation

Keywords

  • siRNA
  • mCD14
  • TNF-α
  • MIP-2
  • IL-6
  • NO
  • LPS
  • RAW264.7 cell